Kala Bio Inc share price logo

Kala Bio Inc Share Price

NASDAQ: KALA

Small Cap

$0.18

-0.02

(-11.80%)

as on

Kala Bio Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.16
    $0.20
    downward going graph

    11.11%

    Downside

    11.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.16
    $20.60
    downward going graph

    10.72%

    Downside

    11344.44%

    Upside

    downward going graph

Kala Bio Inc share price movements today

Previous Close
$0.20
Open
$0.20
Volume
6.6M
Day's Low - High
$0.16 - $0.20
52 Week Low - High
$0.16 - $20.60

Kala Bio Inc Historical Returns

1 Month Return
-53.76 %
3 Month Return
-72.97 %
1 Year Return
-97.1 %
3 Year Return
-98.88 %
5 Year Return
-99.95 %

Kala Bio Inc Stock Fundamentals & Key Indicators

Check Kala Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$182.3M

EPS (TTM)

-4.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.14

Industry PE ratio

-3.575277777777778

PEG Ratio

0

EBITDA

-41.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-708.34%

Kala Bio Inc Stock Valuation

Track how Kala Bio Inc P/E has moved over time to understand its valuation trends.

Kala Bio Inc in the last 5 years

  • Overview

  • Trends

Lowest (-3.99x)

March 31, 2021

Industry (-3.58x)

March 28, 2026

Today (-3.14x)

March 28, 2026

Highest (-0.26x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.14x

Kala Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kala Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Kala Bio Inc image
Kala Bio Inc
BUY$182.3M-99.95%-3.140.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.5B132.92%140.848.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.2B101.77%29.5832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.8BNA112.585.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.0B54.69%18.2531.41%

Stock Returns calculator for Kala Bio Inc Stock including INR - Dollar returns

The Kala Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Kala Bio Inc investment value today

Current value as on today

₹13,484

Returns

₹86,516

(-86.52%)

Returns from Kala Bio Inc Stock

₹97,025 (-97.02%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Kala Bio Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Kala Bio Inc. Average target price of $1.5

Kala Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Kala Bio Inc.

What analysts predicted

88%UPSIDE

Target Price

$1.5

Current Price

$0.18

Analyzed by

9 Analysts

Target

$1.50

Kala Bio Inc target price $1.5, a slight upside of 88% compared to current price of $0.18. According to 9 analysts rating.

Kala Bio Inc Stock’s Investor Sentiment and Interest

Investment in Kala Bio Inc Shares on INDmoney has grown by 239.13% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:239.13% versus previous 30 day period

Search interest for Kala Bio Inc Stock has increased by 196% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:196% versus previous 30 day period

Kala Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-9
-8
-9
-11
-9
-9
-9
-10
-10
-7
EBITDA
-8
-7
-7
-10
-8
-7
-6
-7
-10
-6
Interest Expense
1
1
1
1
1
1
1
1
1
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-8
-8
-11
-9
-8
-8
-8
-11
-7
Income Tax Expense
1
0
-5
0
-
-
0
-
-
-
Net Income
-10
-8
-8
-11
-9
-8
-8
-8
-11
-7
Net Profit Margin
0.00%
0.00%
-12324.29%
0.00%
0.00%
0.00%
-3218.50%
0.00%
0.00%
0.00%

Kala Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
-
-
6
6
11
3
-
-
Gross Profit
0
0
0
0
4
3
7
1
0
0
Operating Income
-15
-32
-39
-64
-88
-96
-109
-81
-39
-40
EBITDA
-15
-32
-40
-62
-83
-92
-131
-36
-36
-40
Interest Expense
0
0
1
3
8
8
8
7
5
5
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-16
-33
-42
-66
-94
-104
-142
-44
-42
-38
Income Tax Expense
0
0
0
1
7
7
9
-44
-
-
Net Income
-16
-33
-42
-66
-94
-104
-142
-44
-42
-38
Net Profit Margin
-37071.11%
0.00%
0.00%
0.00%
-1553.29%
-1639.85%
-1268.73%
-1151.64%
0.00%
0.00%

Kala Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-8
-8
-11
-9
-8
-8
-8
-11
-7
Operating Cash Flow
-2
-7
-10
-9
-4
-4
-8
-7
-10
Investing Cash Flow
9
0
0
0
0
0
-
0
0
Financing Cash Flow
0
2
8
14
0
6
0
-2
0
Change in Cash
6
-5
-2
5
-4
1
-8
-10
-10

Kala Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-33
-42
-66
-94
-104
-142
-44
-42
-38
Operating Cash Flow
-27
-34
-54
-92
-90
-108
-78
-27
-29
Investing Cash Flow
0
0
-1
-1
-78
70
62
0
0
Financing Cash Flow
67
103
124
8
160
42
-7
8
29
Change in Cash
39
69
68
-85
-8
5
-24
-19
0

Global Institutional Holdings in Kala Bio Inc

Funds
Holdings
Woodline Partners LP
0.02%
Vanguard Group Inc
0.01%
Tower Research Capital LLC
0%
Two Sigma Investments LLC
0%
XTX Topco Ltd
0.18%
See all

Kala Bio Inc News & Key Events

  • img

    Today's Timeline - 29 September

    Mon, 09:30 PM

    -

    Kala Bio halts KPI-012 development after trial fails to meet primary endpoints, plans workforce reduction and strategic evaluations.

Insights on Kala Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -11.15M → -7.56M (in $), with an average increase of 47.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 70.0K → 254.0K (in $), with an average increase of 72.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 115.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 167.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KALA stock has moved down by -25.8%

About Kala Bio Inc

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at www.kalarx.com.
OrganisationKala Bio Inc
Headquarters1167 Massachusetts Avenue, Arlington, MA, United States, 02476
IndustryHealth Technology
CEOMr. Avi Minkowitz
E-voting on sharesClick here to vote

Key Management of Kala Bio Inc

Name

Title

Mr. Vincent Kosewski

Senior VP of Manufacturing & Supply Chain Management

Dr. Francis S. Mah M.D.

Chief Medical Advisor

Mr. Josiah Craver CPA

Senior VP & Corporate Controller

Mr. Carl Rennie

Executive Director of Account Management

Mr. Avi Minkowitz

CEO, CFO & Director

Dr. Justin Hanes Ph.D.

Founder & Chair of the Scientific Advisory Board

Ms. Jill S. Steier

Executive Director of Investor Relations & Corporate Communications

Dr. R. Kim Brazzell Ph.D.

Head of R&D and Chief Medical Officer

Mr. Todd Bazemore

Principal Executive Officer & Director

Mr. Darius Kharabi J.D., M.B.A.

Chief Business Officer

FAQs

What is Kala Bio Inc share price today?

Kala Bio Inc share price today is $0.18 as on at the close of the market. Kala Bio Inc share today touched a day high of $0.2 and a low of $0.16.

What is the 52 week high and 52 week low for Kala Bio Inc share?

Kala Bio Inc share touched a 52 week high of $20.6 on and a 52 week low of $0.16 on . Kala Bio Inc stock price today i.e. is closed at $0.18,which is 99.13% down from its 52 week high and 12.01% up from its 52 week low.

What is Kala Bio Inc's market capitalisation today?

Kala Bio Inc market capitalisation is $0.00T as on .

How to invest in Kala Bio Inc Stock (KALA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kala Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kala Bio Inc Shares that will get you 8.3333 shares as per Kala Bio Inc share price of $0.18 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Kala Bio Inc Stock (KALA) from India?

Indian investors can start investing in Kala Bio Inc (KALA) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Kala Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kala Bio Inc share’s latest price of $0.18 as on March 28, 2026 at 1:29 am IST, you will get 55.5556 shares of Kala Bio Inc. Learn more about fractional shares .

What are the returns that Kala Bio Inc has given to Indian investors in the last 5 years?

Kala Bio Inc stock has given -99.95% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?